Navigation Links
HeartWare Presentation at the UBS Global Life Sciences Conference to be Webcast
Date:9/14/2012

FRAMINGHAM, Mass. and SYDNEY, Sept. 14, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the UBS Global Life Sciences Conference at 8:00 a.m. EDT on Wednesday, September 19, 2012.  The conference is being held September 19-20, 2012 at the Grand Hyatt in New York City.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union and TGA approval in Australia.  The device is currently the subject of United States clinical trials for two indications: bridge-to-transplant and destination therapy.  For additional information, please visit www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

HEARTWARE, HVAD, MVAD and HeartWare logos are registered trademarks of HeartWare, Inc.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Presentation At The Canaccord Genuity 32nd Annual Growth Conference To Be Webcast
2. HeartWare Presentation at the 2012 Wedbush PacGrow Lifesciences Management Access Conference to be Webcast
3. HeartWare Reports Second Quarter 2012 Results
4. HeartWare Completes Acquisition Of World Heart Corporation
5. HeartWare Schedules Second Quarter Conference Call And Webcast
6. HeartWare Names Peter F. McAree Chief Financial Officer
7. HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart Failure
8. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
9. HeartWare Presentation at the Bank of America Merrill Lynch 2012 Health Care Conference to be Webcast
10. Heartware Schedules First Quarter Conference Call And Webcast
11. HeartWare Stock Trading Halted Today; FDA Advisory Committee to Review HeartWare® Ventricular Assist System as a Bridge to Heart Transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... , Jan. 17, 2017 Following an ... today praised the Food and Drug Administration,s (FDA,s) ... Human Drug Products by Pharmacies and Outsourcing Facilities." ... proposed limitation on pre-packaging -- which would have ... costs to long term care (LTC) pharmacies.  ...
(Date:1/17/2017)... ReportsnReports.com adds "Anaphylaxis - Pipeline Review, H2 2016" ... Anaphylaxis,s therapeutic pipeline with comprehensive information on the therapeutic development ... assessment by drug target, mechanism of action (MoA), route of ... featured news and press releases. ... Complete report on H2 2016 pipeline ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket knife, luggage ... Cradle to Cradle Product Design Challenge , the Cradle to Cradle Products Innovation ... circular design challenges scheduled to run through early 2018. The challenges are presented by ...
(Date:1/17/2017)... ... 2017 , ... SC&H Group, a leading audit, tax, and consulting firm, announced ... Advisory Services practice . Rossi is the third technology consulting leader to join SC&H ... grows, and the practice continues to expand.     , Bringing more than 25 years of ...
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers ... has announced the latest beneficiary of their thriving community involvement program. The current ... to fulfilling the dreams of terminally ill patients. Donations to this worthy cause ...
(Date:1/17/2017)... Falls, NJ (PRWEB) , ... January 17, 2017 ... ... and Learning Center and the Montclair State University’s Athletic Training Education program forged ... State University’s Athletic Training Education Program, which is consists of both student ...
(Date:1/16/2017)... York, NY (PRWEB) , ... January 16, 2017 , ... ... grand opening of a new showroom in East Hanover, New Jersey. , “We are ... Gym Source. “The new innovative in-store concept is designed to give clients a seamless ...
Breaking Medicine News(10 mins):